Back to Journals » Therapeutics and Clinical Risk Management » Volume 5

Pharmacotherapy of pediatric and adolescent HIV infection

Authors Schuval S

Published 18 June 2009 Volume 2009:5 Pages 469—484

DOI https://doi.org/10.2147/TCRM.S4594

Review by Single-blind

Peer reviewer comments 2


Susan J Schuval1,2

1Division of Allergy/immunology, Department of Pediatrics, North Shore – Long island Jewish Health System, Great Neck, NY, USA; 2Associate Professor of Clinical Pediatrics, Albert Einstein College of Medicine, Bronx, NY, USA

Abstract: Significant advances have been made in the treatment of human immunodeficiency virus (HIV) infection over the past two decades. Improved therapy has prolonged survival and improved clinical outcome for HIV-infected children and adults. Sixteen antiretroviral (ART) medications have been approved for use in pediatric HIV infection. The Department of Health and Human Services (DHHS) has issued “Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection”, which provide detailed information on currently recommended antiretroviral therapies (ART). However, consultation with an HIV specialist is recommended as the current therapy of pediatric HIV therapy is complex and rapidly evolving.

Keywords: antiretroviral, HAART, Pediatric Guidelines, HIV, AIDS

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]